| NCT ID | NCT05373498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Leipzig Heart Science gGmbH |
| Condition | Cardiac Arrest |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2022-08-18 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2022-08-18 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Children with congenital heart defects are far more likely to suffer a cardiovascular arrest and be in the need of cardiopulmonary resuscitation than healthy children or those with diseases of other organ systems, especially after cardiothoracic surgery. Due to a lack of data, the exact number of resuscitations in this patient cohort, as well as the morbidity and mortality, is unknown. This study aims to register all cardiovascular arrests in pediatric patients with congenital heart disease and study the mortality and morbidity with a special focus on the neurodevelopmental outcome.
Eligibility Criteria
Inclusion Criteria: * congenital heart defects, congenital heart arrhythmia, familial cardiomyopathies, inflammatory heart diseases * pediatric resuscitation (chest compressions ≥2min) in hospital or on arrival in hospital * age \<18 years * informed consent of the parents or legal representative Exclusion Criteria: * absence or withdrawal of informed consent of the parents or legal representative * do-not-resuscitate-order (DNR)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05373498 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05373498 currently recruiting?
Yes, NCT05373498 is actively recruiting participants. Contact the research team at Franziska.Markel@helios-gesundheit.de for enrollment information.
Where is the NCT05373498 trial being conducted?
This trial is being conducted at Leipzig, Germany, Berlin, Germany, Bonn, Germany.
Who is sponsoring the NCT05373498 clinical trial?
NCT05373498 is sponsored by Leipzig Heart Science gGmbH. The trial plans to enroll 400 participants.